Patent Assignment
Reel/Frame 021089/0547
Assignment of Assignor's Interest
Recorded: 2008-06-12
Pages: 3
Assignor
DEFREES, SHAWN
Executed: 2007-10-15
Assignee
NEOSE TECHNOLOGIES, INC.
102 ROCK ROAD, HORSHAM, PENNSYLVANIA, 19044
Covered Property
(1)
Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf)
Application:
11/665,908 →
Publication:
US 2008/0176790
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 23, 2009
From: NEOSE TECHNOLOGIES, INC.
To: NOVO NORDISK A/S
Reel/Frame 022441/0937 →
Corrective Assignment to Correct the Please Change the Assignee from Biogenerix Ag to Novo Nordisk a/S. Previously Recorded on Reel 022404 Frame 0634. Assignor(S) Hereby Confirms the Assignor(S) Hereby Confirms the Correct Assignee Is Novo Nordisk a/S, Novo Alle, 2880 Bagsvaerd, Denmark.
Apr 9, 2009
From: BIOGENERIX AG
To: NOVO NORDISK A/S
Reel/Frame 022527/0614 →
Assignment of Assignor's Interest
Aug 21, 2019
From: RATIOPHARM GMBH; TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.
To: 89BIO LTD.
Reel/Frame 050112/0408 →
Corrective Assignment to Correct the Application Number 62/623342 Previously Recorded on Reel 050112 Frame 0408. Assignor(S) Hereby Confirms the License Assignment.
Oct 24, 2019
From: RATIOPHARM GMBH; TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.
To: 89BIO LTD.
Reel/Frame 050817/0001 →
Assignment of Assignor's Interest
Oct 6, 2025
From: 89BIO LTD.
To: 89BIO, INC.
Reel/Frame 072478/0305 →